Cargando…

Editorial: Targeting tumor vasculature to enhance cancer immunotherapy

Detalles Bibliográficos
Autores principales:	Yang, Jieying, Fu, Li, Shirakawa, Toshiro, Xiang, Tong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151897/ https://www.ncbi.nlm.nih.gov/pubmed/37143939 http://dx.doi.org/10.3389/fonc.2023.1199811

Ejemplares similares

Editorial: Engineered Targeted Cancer Immunotherapies
por: Fantini, Massimo, et al.
Publicado: (2022)

Immunotherapies targeting tumor vasculature: challenges and opportunities
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2023)

Editorial: Advances in Combination Tumor Immunotherapy
por: Curran, Michael A., et al.
Publicado: (2015)

Editorial: Epigenetic Regulation and Tumor Immunotherapy
por: Sun, Hongyin, et al.
Publicado: (2022)

Editorial: Novel immunotherapies to treat gastrointestinal solid tumor cancers
por: Sureban, Sripathi M., et al.
Publicado: (2022)

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies
por: Decock, Julie, et al.
Publicado: (2023)

Control of the Adaptive Immune Response by Tumor Vasculature
por: Mauge, Laetitia, et al.
Publicado: (2014)

TAM-targeted reeducation for enhanced cancer immunotherapy: Mechanism and recent progress
por: Shen, Xinyuan, et al.
Publicado: (2022)

Editorial: Personalized immunotherapy for cancer
por: Pasetto, Anna, et al.
Publicado: (2023)

Editorial: Strategies to overcome tumor evasion and resistance to immunotherapies by targeting immune suppressor cells
por: Saida, Yu, et al.
Publicado: (2023)

Editorial: The interconnection between the tumor microenvironment and immunotherapy in brain tumors
por: Qu, Chunrun, et al.
Publicado: (2023)

Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature
por: Hooglugt, Aukie, et al.
Publicado: (2021)

Editorial: Immunotherapy for Tumor in the Brain: Insights From—and For—Other Tumor Sites
por: Lampson, Lois A.
Publicado: (2018)

Editorial: Impact of immunotherapy in lung cancer
por: Ferreira, Marion, et al.
Publicado: (2022)

Editorial: Microbiota and metabolites in cancer immunotherapy
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
por: Li, Ying, et al.
Publicado: (2023)

Editorial: Mechanisms of resistance to the targeted therapy and immunotherapy in cutaneous melanoma
por: Premi, Sanjay, et al.
Publicado: (2022)

Targeting the tumor vasculature to enhance T cell activity
por: Lanitis, Evripidis, et al.
Publicado: (2015)

Editorial: Immunotherapy in Hepatocellular Carcinoma
por: Li, Bin, et al.
Publicado: (2021)

Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Editorial: Advancements in immunology and immunotherapy for breast cancer
por: Sugie, Tomoharu, et al.
Publicado: (2022)

Editorial: Emerging engineering approaches in cancer immunotherapy
por: Xu, Jialu, et al.
Publicado: (2022)

Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy
por: Fereydouni, Mohammad, et al.
Publicado: (2022)

Targeting collagen in tumor extracellular matrix as a novel targeted strategy in cancer immunotherapy
por: Liu, Jiayang, et al.
Publicado: (2023)

Editorial: Tumor immune microenvironment topographies for prediction and evaluation: unlock the mystery of the therapeutic effects and adverse events of tumor immunotherapy
por: Yin, Xiaoran, et al.
Publicado: (2023)

Editorial: The role of immunotherapy in melanomas
por: Fateeva, Anna, et al.
Publicado: (2023)

Editorial: Biomarkers and immunotherapy of hepatic-biliary-pancreatic cancers
por: Qian, Yawei, et al.
Publicado: (2023)

Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
por: Abu Eid, Rasha
Publicado: (2019)

Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
por: Tolba, Mai F., et al.
Publicado: (2021)

Editorial: New Insights into the Complexity of Tumor Immunology in B-cell Malignancies: Tumor Immunology and Immunotherapy
por: Seiffert, Martina, et al.
Publicado: (2022)

Vascular Co-Option and Other Alternative Modalities of Growth of Tumor Vasculature in Glioblastoma
por: Ribatti, Domenico, et al.
Publicado: (2022)

Bevacizumab-Induced Tumor Vasculature Normalization and Sequential Chemotherapy in Colorectal Cancer: An Interesting and Still Open Question
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Vasculature Disruption Enhances Bacterial Targeting of Autochthonous Tumors
por: Drees, Jeremy J., et al.
Publicado: (2015)

Targeting T Cell Immunometabolism for Cancer Immunotherapy; Understanding the Impact of the Tumor Microenvironment
por: Mockler, Mary B., et al.
Publicado: (2014)

Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factors
por: Ugel, Stefano, et al.
Publicado: (2023)

Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer
por: Al-Rajabi, Taiseer, et al.
Publicado: (2023)

Editorial: Genomics and Epigenomics of Cancer Immunotherapy: Challenges and Clinical Implications
por: Abedalthagafi, Malak
Publicado: (2021)

Editorial: The Evolving Role of Immunotherapy in Non-Melanoma Skin Cancers
por: Guida, Michele, et al.
Publicado: (2022)

Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
por: Schaaf, Marco B., et al.
Publicado: (2018)

Editorial: Imaging assessment of response to immunotherapy
por: Occhipinti, Mariaelena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3ekadrmt5va0l3pl0hslc47ua1